The association analysis in this study revealed that patients with adenocarcinoma and smokers were more likely to exhibit higher mRNA expression levels of BRCA1. Therefore, it was hypothesized that smoking patients with adenocarcinoma would not benefit from cisplatin and antimicrotubule therapies. This evidence concerns the gene BRCA1 and adenocarcinoma.